NCT02324530

Brief Summary

This is a clinical study on patients to compare the effects of CPAP on lung volume diaphragm motion, heart position and tumor motion compared to free breathing. Only patients with significant tumor motion of greater than 1 cm amplitude or unfavorable chest wall geometry (heart close to chest wall) identified on standard imaging and simulation will be candidates for the study. Patients will be re- simulated and planned for radiation treatments with CPAP. The radiation plans generated with and without CPAP will be compared to evaluate the impact of CPAP on tumor motion and dose delivered to adjacent critical structures such as the heart and lung.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 10, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 24, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

December 24, 2014

Status Verified

December 1, 2014

Enrollment Period

2 years

First QC Date

December 10, 2014

Last Update Submit

December 18, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in amplitude of tumor motion

    Measurement of the Internal Target Volume in cc

    2 months

Secondary Outcomes (1)

  • Reduction of radiation dose to critical organs

    2 months

Other Outcomes (1)

  • Tolerability of CPAP

    immediate

Study Arms (3)

Lung tumors

EXPERIMENTAL

Patients with \> 1 cm tumor motion simulated using 4DCT with and without CPAP

Device: Continuous positive airway pressure (CPAP)

Left sided Breast cancer

EXPERIMENTAL

Patients with heart abutting chest wall will be simulated using 4DCT with and without CPAP

Device: Continuous positive airway pressure (CPAP)

Abdominal tumors

EXPERIMENTAL

Patient with liver metastases for SBRT or pancreatic tumors will be simulated using 4DCT with and without CPAP

Device: Continuous positive airway pressure (CPAP)

Interventions

CT simulation with and without CPAP

Abdominal tumorsLeft sided Breast cancerLung tumors

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Lung tumors and nodules with tumor motion greater than 1 cm on standard imaging
  • Left sided breast tumors with unfavorable anatomy, viz heart abutting chest wall
  • Upper abdominal tumors: Liver and Pancreas with tumor motion greater than 1 cm. (n=10)

You may not qualify if:

  • Under 18 years old
  • Inability to sign informed consent
  • Pregnancy,
  • Mental Illness,
  • Not legally competent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba_Medical_Center

Tel Litwinsky, 5262160, Israel

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsBreast NeoplasmsAbdominal Neoplasms

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Zvi Symon, MD

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR
  • Jeffrey Goldstein, MD

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR
  • Yaacov R Lawrence, MD

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman Radiation Oncology

Study Record Dates

First Submitted

December 10, 2014

First Posted

December 24, 2014

Study Start

December 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

December 24, 2014

Record last verified: 2014-12

Locations